Purchases and Sales Made in Q2 2023 in Anavex Life Sciences Corp. (AVXL)
This table provides information about the institutional ownership of Anavex Life Sciences Corp. (AVXL) during Q2 2023. The information is specifically focused on institutions that hold shares of ANAVEX LIFE SCIENCES CORP..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-36.4K- 76.31% |
$279K - $346K
|
11.3K
$115K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-49.6K- 27.19% |
$380K - $471K
|
133K
$1.35M
|
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-56.9K- 83.17% |
$436K - $540K
|
11.5K
$117K
|
|
|
Aug 11, 2023
Q2 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-115K- 24.63% |
$878K - $1.09M
|
351K
$3.56M
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-144K- 55.27% |
$1.1M - $1.37M
|
116K
$1.18M
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-154K- 85.11% |
$1.18M - $1.46M
|
26.9K
$273K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-254K- 67.17% |
$1.94M - $2.41M
|
124K
$1.26M
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-352K- 52.34% |
$2.69M - $3.34M
|
320K
$3.25M
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-352K- 52.34% |
$2.69M - $3.34M
|
320K
$3.25M
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-578K- 69.1% |
$4.43M - $5.49M
|
259K
$2.62M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.27M- 22.34% |
$9.72M - $12.1M
|
4.41M
$44.8M
|